By admin.bio No comments yet
Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.
How lyophilised reagent beads can reduce waste
30th March 2022
Welcome to the team Megan, Ish and Georgina
25th March 2022
Four tips to mitigate the risk of single source IVD assay manufacturing
23rd February 2022